AngioDynamics falls as jury finds it violated Becton Dickinson patents

Becton Dickinson and Co

23/11/2022 18:33

** Shares of AngioDynamics Inc  ANGO.O  fall 10.9% to
$13.04, nearly 1-mth low, after jury determined some of its
implantable port products infringed certain U.S. patents held by
Becton Dickinson  BDX.N 
    ** Verdict entered on Tues after one-week trial in case
brought by BDX subsidiaries C.R. Bard, Inc. and Bard Peripheral
Vascular Inc. in U.S. District Court for the District of
Delaware, ANGO announced in regulatory filing
    ** Other matters, including patent eligibility issues and
extent of damages remain to be decided, per the filing
    ** "The Company strongly disagrees with the claims and the
verdict, and believes the verdict is not supported by the facts
of the case or the law, and is the result of error," ANGO said,
adding it plans to appeal
    ** ANGO's shares last off 7.2% at $13.58. Stock has lost
about a third of its value since end-Sept
    ** BDX's shares  edge up 0.1% to $235.84 on the session
 (Lance Tupper is a Reuters market analyst. The views expressed
are his own)
 ((lance.tupper@thomsonreuters.com
lance.tupper@tr.com 1-332-219-1430))